Life-sciences patent originators lead live San Diego partner briefs. First, IP originators who can move inventor relationships without a total conflicts wipeout. Second, biotech corporate partners next to venture and strategic financings. Third, technology and data-privacy partners who hold product and clinical-data work. Fourth, employment partners paired to growth-company headcount. Fifth, litigation partners with commercial or IP concentration where public dockets make diligence cleaner.
NALP’s May 2026 Bulletin on 2025 lateral hiring recorded a 17.8% year-over-year rise in U.S. lateral partner volume and a 20.8% overall lateral increase across West/Rocky Mountain offices—national inertia that still shows up on San Diego science desks even when California Q1 2026 partner flow softened. Public 2025–2026 moves—Goodwin reopening San Diego with a patents co-chair from Wilson Sonsini, Latham’s High Bluff life-sciences work, Cooley and Pillsbury pricing the same biotech corridor—match our San Diego mandate telemetry on the 15 closed partner searches of the last three years: roughly 60% life-sciences or IP franchise, about 20% corporate or technology, about 13% disputes or employment, and only one multi-partner practice-group transplant.
Live confidential work typically includes Am Law 50–100 single-partner life-sciences adds, two-partner IP-and-corporate pods, and disputes partners for company-side dockets. Candidate-side interest is highest among partners whose originations have outgrown platform credit or who face a conflicts wall another firm can clear.